Skip to main content
Equibles
CLPT logo

CLPT · ClearPoint Neuro, Inc. · Metrics

Track CLPT — free

Use CLPT with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research CLPT.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$9.25 -0.20 (-2.12%) At close · Oct 21
Russell 2000 member Rebalance outlook locked
Market Cap
$282.16M
Shares
30.50M
Volume · Oct 21 410.35K Avg daily vol (3M) 658.58K

CLPT metrics

89 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$9.25
Market cap
$282.16M

Price action

20 metrics
Price change (1W)
-3.7%
Price change (30D)
-32.4%
Price change (3M)
-38.7%
Price change (6M)
-11.8%
Price change (YTD)
-30.9%
Price change (1Y)
-65.4%
Trailing year
Price change (5Y)
-47.5%
52-week high
$27.32
52-week low
$8.66
Change from 52-week high
-65.4%
Change from 52-week low
+9.1%
Annualized volatility
87.9%
Annualized volatility (3M)
81.3%
Beta
1.8
RSI (14D)
33.4
Price vs SMA 50
-29.4%
Price vs SMA 200
-28.3%
Avg volume (3M)
660,374
Relative volume
0.7
Average dollar volume
$8.79M

Company

3 metrics
Sector
Healthcare
Industry
Medical Devices
Shares outstanding
30.50M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
7.3×
reciprocal yield 13.7%
EV / EBITDA
—
EV / EBIT
—
P / sales
6.8×
reciprocal yield 14.7%
P / book
26.8
reciprocal yield 3.7%
FCF yield
-10.8%
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-12.0%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
9.2×
reciprocal yield 10.9%
EV / revenue historical average (5Y)
11.2×
reciprocal yield 8.9%
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
2026-10-28
Last earnings
2026-08-03

Profitability

9 metrics
Gross margin
62.6%
Operating margin
-73.4%
Trailing 12 months
Net margin
-81.8%
Gross profit (TTM)
$26.47M
Operating profit (TTM)
−$31.04M
Net income (TTM)
−$34.57M
Trailing 12 months
Diluted EPS (TTM)
$-1.17
FCF margin
-73.9%
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
$1.44
Gross profit per diluted share (TTM)
$0.90
Operating profit per diluted share (TTM)
$-1.06
EBITDA per diluted share (TTM)
$-1.04
Net income per diluted share (TTM)
$-1.18
Operating cash flow per diluted share (TTM)
$-1.03
Free cash flow per diluted share (TTM)
$-1.07
Capital expenditures per diluted share (TTM)
$0.04
R&D per diluted share (TTM)
$0.54
Stock compensation per diluted share (TTM)
$0.29
Book value per share
$0.95

Growth

11 metrics
Revenue growth YoY
+18.1%
Year over year
Net income growth YoY
—
Revenue (TTM)
$42.28M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+6.8%
Year over year · more shares
Revenue CAGR (3Y)
+21.6%
Revenue CAGR (5Y)
+23.6%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-320.8%
Return on assets
-39.8%
Debt / equity
4.7
Current ratio
4.7
EBITDA (TTM)
−$30.49M
Free cash flow (TTM)
−$31.27M
Quick ratio
3.9
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
−$20.87M
Latest balance sheet
Cash & equivalents
$29.36M
Total assets
$86.74M
Total debt
$50.23M

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$30.16M
Capital expenditures (TTM)
$1.11M
R&D (TTM)
$15.84M
SG&A (TTM)
$19.58M
Stock compensation (TTM)
$8.49M
R&D / revenue
37.5%
Stock compensation / revenue
20.1%

Ownership (13F)

9 metrics
13F filers
130
13F filer change QoQ
+8
Institutional ownership
48.5%
Conviction holders (share of 13F filers)
1.6%
Crowding (high-turnover and private-fund holders)
16.7%
Private-fund adviser ownership
14.8%
Active holders' share change QoQ
+5.5%
Holder tenure
9.5
Price vs estimated holder cost
+39.9%

Ownership (registered funds)

1 metrics
Index-fund ownership
12.3%

Short interest

3 metrics
Short interest
15.6%
Latest settlement · 6.0 days to cover
Days to cover
6.0d
Short-squeeze score
83 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1285550 CUSIP 18507C103 13F (30d) 10 filings 10 filers Visit website Investor relations